Institut du Cancer de Montpellier — Montpellier

Public research footprint of Institut du Cancer de Montpellier, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Squamous Non Small Cell Lung Cancer (NSCLC-SCC) · First Progression of Glioblastoma · Ovarian Cancer, Ovarian Neoplasms

Recently updated registry entries

NCT06662786 — A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… (Recruiting)
NCT06627595 — Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management (Recruiting)
NCT06161025 — A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Institut du Cancer de Montpellier?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.